Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2008

Open Access 01-03-2008 | Gastrointestinal Oncology

Is There a Place for Esogastric Cancer Surgery in Cirrhotic Patients?

Author: Christophe Mariette, MD, PhD

Published in: Annals of Surgical Oncology | Issue 3/2008

Login to get access

Excerpt

It is well established that surgery, especially gastrointestinal cancer surgery, in nonbleeding cirrhotic patients carries a high risk of mortality and morbidity. Esophagogastrectomy for carcinoma in cirrhotic patients has been mentioned only occasionally in the literature. Our aim was to review literature results in esophageal and gastric cancer surgery, to identify cirrhotic patients who will benefit from surgery, and to give to surgeons technical specificities of such surgery. …
Literature
1.
Garrison RN, Cryer HM, Howard DA, Polk HC Jr. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg 1984; 199:648–55PubMedCrossRef
2.
Doberneck RC, Sterling WA Jr, Allison DC. Morbidity and mortality after operation in nonbleeding cirrhotic patients. Am J Surg 1983; 146:306–9PubMedCrossRef
3.
Fekete F, Belghiti J, Cherqui D, et al. Results of esophagogastrectomy for carcinoma in cirrhotic patients. A series of 23 consecutive patients. Ann Surg 1987;206:74–8PubMedCrossRef
4.
Tachibana M, Kotoh T, Kinugasa S, et al. Esophageal cancer with cirrhosis of the liver: results of esophagectomy in 18 consecutive patients. Ann Surg Oncol 2000; 7:758–63PubMedCrossRef
5.
Lu MS, Liu YH, Wu YC, Kao CL, Liu HP, Hsieh MJ. Is it safe to perform esophagectomy in esophageal cancer patients combined with liver cirrhosis? Interact Cardiovasc Thorac Surg 2005; 4:423–5PubMedCrossRef
6.
Mariette C, Piessen G, Lamblin A, Mirabel X, Adenis A, Triboulet JP. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma. Br J Surg 2006; 93:1077–83PubMedCrossRef
7.
Mariette C, Piessen G, Balon JM, Van Seuningen I, Triboulet JP. Surgery alone in the curative treatment of localised oesophageal carcinoma. Eur J Surg Oncol 2004; 30:869–76PubMedCrossRef
8.
Jang HJ, Kim JH, Song HH, et al. Clinical outcomes of patients with liver cirrhosis who underwent curative surgery for gastric cancer: a retrospective multi-center study. Dig Dis Sci 2007; Jun 28 [E-pub]
9.
Isozaki H, Okajima K, Ichinona T, et al. Surgery for gastric cancer in patients with cirrhosis. Surg Today 1997; 27:17–21PubMedCrossRef
10.
Sano T, Sasako M, Yamamoto S, et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy—Japan Clinical Oncology Group study 9501. J Clin Oncol 2004; 22:2767–73PubMedCrossRef
11.
Lee JH, Kim J, Cheong JH, et al. Gastric cancer surgery in cirrhotic patients: result of gastrectomy with D2 lymph node dissection. World J Gastroenterol 2005; 11:4623–7PubMed
12.
Karl RC, Schreiber R, Boulware D, et al. Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy. Ann Surg 2000; 231:635–43PubMedCrossRef
13.
Liu CL, Fan ST, Lo CM, et al. Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases. Ann Surg 2004; 239:194–201PubMedCrossRef
14.
Takeda J, Toyonaga A, Koufuji K, et al. Surgical management of gastric cancer patients with liver cirrhosis. Kurume Med J 1994; 41:205–13PubMed
15.
Takeda J, Hashimoto K, Tanaka T, et al. Review of operative indication and prognosis in gastric cancer with hepatic cirrhosis. Hepatogastroenterology. 1992; 39:433–6PubMed
16.
Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 2007; 8:545–53PubMedCrossRef
Metadata
Title
Is There a Place for Esogastric Cancer Surgery in Cirrhotic Patients?
Author
Christophe Mariette, MD, PhD
Publication date
01-03-2008
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 3/2008
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-007-9765-1

Other articles of this Issue 3/2008

Annals of Surgical Oncology 3/2008 Go to the issue

Head and Neck Oncology

Analysis of Risk Factors of Predictive Local Tumor Control in Oral Cavity Cancer

Breast Oncology

In Reply

Hepatic and Pancreatic Tumors

A Novel Function of the Receptor for Advanced Glycation End-Products (RAGE) in Association with Tumorigenesis and Tumor Differentiation of HCC

Hepatic and Pancreatic Tumors

Delayed Visceral Arterial Hemorrhage Following Whipple’s Procedure: Minimally Invasive Treatment with Covered Stents

Gastrointestinal Oncology

VEGF Expression Predicts Survival in Patients with Peritoneal Surface Metastases from Mucinous Adenocarcinoma of the Appendix and Colon

Breast Oncology

S-Classification of Sentinel Lymph Node Predicts Axillary Nonsentinel Lymph Node Status in Patients with Breast Cancer